287 related articles for article (PubMed ID: 11657635)
1. Prospecting for genetic gold: compensating genetic research donors.
Triber GA
J Biolaw Bus; 1998; 2(1):20-8. PubMed ID: 11657635
[No Abstract] [Full Text] [Related]
2. Gene treaty promises rewards for unique peoples.
Coghlan A
New Sci; 1996 Nov; 152(2054):8. PubMed ID: 11656591
[No Abstract] [Full Text] [Related]
3. DNA banking and informed consent -- part 2.
Weir RF; Horton JR
IRB; 1995; 17(5-6):1-8. PubMed ID: 11653356
[No Abstract] [Full Text] [Related]
4. Tissue banking: genetic donations and informed consent.
Swibel LH
Princet J Bioeth; 1999; 2(1):6-17. PubMed ID: 11658144
[No Abstract] [Full Text] [Related]
5. Participation in pedigree studies and the risk of impeded access to health insurance.
Kass NE
IRB; 1993; 15(5):7-10. PubMed ID: 11659704
[No Abstract] [Full Text] [Related]
6. Homo economicus: commercialization of body tissue in the age of biotechnology.
Nelkin D; Andrews L
Hastings Cent Rep; 1998; 28(5):30-9. PubMed ID: 11656768
[TBL] [Abstract][Full Text] [Related]
7. Maintaining incentives for bioprospecting: the occasional need for a right to lie.
Heidt R
Berkeley Technol Law J; 1998; 13(2):667-720. PubMed ID: 11979599
[No Abstract] [Full Text] [Related]
8. Scientific imperialism or service to humanity? The complexities of the Human Genome Diversity Project.
Creskoff K
Princet J Bioeth; 1998; 1(1):6-22. PubMed ID: 11657339
[No Abstract] [Full Text] [Related]
9. Moore v. Regents of the University of California: expanded disclosure, limited property rights.
Potts J
Northwest Univ Law Rev; 1992; 86(2):453-96. PubMed ID: 11659500
[No Abstract] [Full Text] [Related]
10. Research that could yield marketable products from human materials: the problem of informed consent.
Levine RJ
IRB; 1986; 8(1):6-7. PubMed ID: 11649703
[No Abstract] [Full Text] [Related]
11. Familial coercion to participate in genetic family studies: is there cause for IRB intervention?
Parker LS; Lidz CW
IRB; 1994; 16(1-2):6-12. PubMed ID: 11652324
[No Abstract] [Full Text] [Related]
12. Biotechnology and the commercial use of human cells: toward an organic view of life and technology.
Martin PA; Lagod ML
Santa Clara Comput High Technol Law J; 1989 Jun; 5(2):211-61. PubMed ID: 11659674
[No Abstract] [Full Text] [Related]
13. Toward the right of commerciality: recognizing property rights in the commercial value of human tissue.
Hardiman R
UCLA Law Rev; 1986 Oct; 34(1):207-64. PubMed ID: 11659048
[No Abstract] [Full Text] [Related]
14. Informed consent: defining limits through therapeutic parameters.
Daar JF
Whittier Law Rev; 1995; 16(1):187-209. PubMed ID: 11660487
[No Abstract] [Full Text] [Related]
15. DNA banking and informed consent -- part 1.
Weir RF; Horton JR
IRB; 1995; 17(4):1-4. PubMed ID: 11654216
[No Abstract] [Full Text] [Related]
16. Source compensation for tissues and cells used in biotechnical research: why a source shouldn't share in the profits.
Dillon TP
Notre Dame Law Rev; 1989; 64(4):628-45. PubMed ID: 11650898
[No Abstract] [Full Text] [Related]
17. Genetic information and property theory.
Barrad CM
Northwest Univ Law Rev; 1993; 87(3):1037-86. PubMed ID: 11656395
[No Abstract] [Full Text] [Related]
18. Structuring the review of human genetics protocols, Part II: diagnostic and screening studies.
Glass KC; Weijer C; Lemmens T; Palmour RM; Shapiro SH
IRB; 1997; 19(3-4):1-13. PubMed ID: 11656943
[No Abstract] [Full Text] [Related]
19. Iceland's genetic $ell-out.
Kolehmainen S
Genewatch; 1999 Feb; 12(1):12-3. PubMed ID: 11660625
[No Abstract] [Full Text] [Related]
20. Patent and be damned!
Sheppard J
Bull Med Ethics; 1997 Jan; No. 124():16-7. PubMed ID: 11655051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
